- Investing Ideas
- Australian Healthcare Undervalued over 20% based on DCF
Australian Healthcare Undervalued over 20% based on DCF
Results
6
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
6 companies
Ramsay Health Care
Market Cap: AU$10.3b
Owns and operates hospitals in Australia and internationally.
RHC
AU$45.00
7D
0.4%
1Y
17.8%
Cochlear
Market Cap: AU$8.9b
Provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and Asia Pacific.
COH
AU$135.48
7D
1.4%
1Y
-55.1%
Ansell
Market Cap: AU$4.8b
Designs, sources, develops, manufactures, distributes, and sells hand and body protection solutions in the Asia Pacific, Europe, the Middle East, Africa, Latin America, the Caribbean, and North America.
ANN
AU$34.90
7D
-1.1%
1Y
11.5%
PolyNovo
Market Cap: AU$739.2m
Designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong.
PNV
AU$1.07
7D
10.9%
1Y
-2.7%
Cogstate
Market Cap: AU$526.6m
A neuroscience solutions company, engages in the creation, validation, and commercialization of digital brain health assessments worldwide.
CGS
AU$3.10
7D
10.7%
1Y
70.3%
Paragon Care
Market Cap: AU$231.7m
Distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia.
PGC
AU$0.14
7D
3.7%
1Y
-64.6%